These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 20473232)
1. Suppression of encephalitogenic T-cell responses by cilostazol is associated with upregulation of regulatory T cells. Wang S; Yan C; Xu H; Zhao X; Han Y Neuroreport; 2010 Jun; 21(9):629-35. PubMed ID: 20473232 [TBL] [Abstract][Full Text] [Related]
3. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases. Wu D; Wang J; Pae M; Meydani SN Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144 [TBL] [Abstract][Full Text] [Related]
4. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells. Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666 [TBL] [Abstract][Full Text] [Related]
5. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis. Ge Z; Da Y; Xue Z; Zhang K; Zhuang H; Peng M; Li Y; Li W; Simard A; Hao J; Yao Z; Zhang R Exp Neurol; 2013 Mar; 241():56-66. PubMed ID: 23261766 [TBL] [Abstract][Full Text] [Related]
6. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses. Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934 [TBL] [Abstract][Full Text] [Related]
7. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model. Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152 [TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation. Oh K; Park HB; Seo MW; Byoun OJ; Lee DS Clin Immunol; 2012 Nov; 145(2):122-32. PubMed ID: 23001131 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells. Souza-Moreira L; Delgado-Maroto V; Morell M; O'Valle F; Del Moral RG; Gonzalez-Rey E Brain Behav Immun; 2013 May; 30():54-60. PubMed ID: 23376169 [TBL] [Abstract][Full Text] [Related]
10. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells. Haghmorad D; Amini AA; Mahmoudi MB; Rastin M; Hosseini M; Mahmoudi M J Neuroimmunol; 2014 Dec; 277(1-2):85-95. PubMed ID: 25457839 [TBL] [Abstract][Full Text] [Related]
11. Salmon proteoglycan suppresses progression of mouse experimental autoimmune encephalomyelitis via regulation of Th17 and Foxp3(+) regulatory T cells. Sashinami H; Asano K; Yoshimura S; Mori F; Wakabayashi K; Nakane A Life Sci; 2012 Dec; 91(25-26):1263-9. PubMed ID: 23069584 [TBL] [Abstract][Full Text] [Related]
12. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation. Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558 [TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE. Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225 [TBL] [Abstract][Full Text] [Related]
15. Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis. Othy S; Hegde P; Topçu S; Sharma M; Maddur MS; Lacroix-Desmazes S; Bayry J; Kaveri SV J Immunol; 2013 May; 190(9):4535-41. PubMed ID: 23526819 [TBL] [Abstract][Full Text] [Related]
16. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. Nizri E; Irony-Tur-Sinai M; Lory O; Orr-Urtreger A; Lavi E; Brenner T J Immunol; 2009 Nov; 183(10):6681-8. PubMed ID: 19846875 [TBL] [Abstract][Full Text] [Related]
17. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D. Matsumoto Y; Fujiwara M Cell Immunol; 1993 Jul; 149(2):268-78. PubMed ID: 7687198 [TBL] [Abstract][Full Text] [Related]
18. Amelioration of experimental autoimmune encephalitis by novel peptides: involvement of T regulatory cells. Shapira E; Brodsky B; Proscura E; Nyska A; Erlanger-Rosengarten A; Wormser U J Autoimmun; 2010 Aug; 35(1):98-106. PubMed ID: 20434883 [TBL] [Abstract][Full Text] [Related]
19. Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function. Kafami L; Etesami I; Felfeli M; Enayati N; Ghiaghi R; Aminian A; Dehpour A J Neuroimmunol; 2013 Feb; 255(1-2):39-44. PubMed ID: 23177720 [TBL] [Abstract][Full Text] [Related]